European expert consensus recommendations on the primary care use of direct oral anticoagulants in patients with venous thromboembolism.

Background: Direct oral anticoagulants for the treatment of venous thromboembolism are supported by robust clinical trial evidence. Despite published guidance, general practitioners are faced with increasingly complex decisions and implementation remains sub-optimal in certain real-world scenarios....

Descripción completa

Detalles Bibliográficos
Publicado en:BMC Primary Care Vol. 25; no. 1; pp. 1 - 11
Autores principales: Patrice, Carter, Ahmet, Fuat, Sylvia, Haas, Elizabeth, Smyth, Carlos, Brotons, Frank, Cools, Rupert, Bauersachs, Richard, Hobbs F. D.
Formato: critical path practice guidelines research tables/charts Journal Article
Publicado: BioMed Central 3/18/2024
Acceso en línea:Ver este registro en EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=176627920&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 176627920
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        27314553
        MZZU
      jtl: BMC Primary Care
      issn: 27314553
      maglogo: N
    pubinfo:
      dt: 3/18/2024
      vid: 25
      iid: 1
      pid: 24147
      pub: BioMed Central
    artinfo:
      ui:
        176627920
        176627920
        176627920
        10.1186/s12875-024-02314-7
        176627920
      ppf: 1
      ppct: 10
      formats:
      tig:
        atl: European expert consensus recommendations on the primary care use of direct oral anticoagulants in patients with venous thromboembolism.
      aug:
        au:
          Patrice, Carter
          Ahmet, Fuat
          Sylvia, Haas
          Elizabeth, Smyth
          Carlos, Brotons
          Frank, Cools
          Rupert, Bauersachs
          Richard, Hobbs F. D.
        affil: https://ror.org/047933096 Health Economics & Outcomes Research Ltd, Rhymney House, Unit A Copse Walk, Cardiff Gate Business Park, CF23 8RB, Cardiff, UK
      sug:
        subj:
          Venous Thromboembolism Drug Therapy
          Anticoagulants Administration and Dosage
          Administration, Oral
          Practice Guidelines
          Consensus
          Primary Health Care Europe
          Physicians, Family
          Medical Practice, Evidence-Based
          Human
          Europe
          Delphi Technique
          Questionnaires
          Physician Attitudes
          After Care
          Drug Efficacy
          Neoplasms Complications
          Family Practice
          Summated Rating Scaling
          Focus Groups
          Descriptive Statistics
          Decision Making, Shared
          Referral and Consultation
          International Normalized Ratio
          Venous Thromboembolism Risk Factors
          Drug Interactions
          Anticoagulants Contraindications
          Kidney Diseases
          Treatment Duration
          Anticoagulants Adverse Effects
          Drug Substitution
          Funding Source
      ab: Background: Direct oral anticoagulants for the treatment of venous thromboembolism are supported by robust clinical trial evidence. Despite published guidance, general practitioners are faced with increasingly complex decisions and implementation remains sub-optimal in certain real-world scenarios. Methods: A two stage formal consensus exercise was performed to formulate consensus statements and a summary guide, facilitating optimal management of direct oral anticoagulants in venous thromboembolism patients by generalist physicians across Europe. An online questionnaire distributed to a broad panel (Phase 1), followed by a virtual panel discussion by an expert group (Phase 2) were conducted. Phase 1 statements covered nine management domains, and were developed via a literature review and expert steering committee. Participants rated statements by their level of agreement. Phase 1 responses were collated and analysed prior to discussion and iterative refinement in Phase 2. Results: In total 56 participants from across Europe responded to Phase 1. The majority had experience working as general practitioners. Consensus indicated that direct oral anticoagulants are the treatment of choice for managing patients with venous thromboembolism, at initiation and for extended treatment, with a review at three to six months to re-assess treatment effect and risk profile. Direct oral anticoagulant choice should be based on individual patient factors and include shared treatment choice between clinicians and patients; the only sub-group of patients requiring specific guidance are those with cancer. Conclusion: Results demonstrate an appreciation of best practices, but highlight challenges in clinical practice. The patient pathway and consensus recommendations provided, aim to highlight key considerations for general practice decision making, and aid optimal venous thromboembolism treatment.
      pubtype: Academic Journal
      doctype:
        critical path
        practice guidelines
        research
        tables/charts
        Journal Article
      ougenre: Article
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N